skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: New Records: New From Last Week remove New Records: New From Last Month remove resource type: Web Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Zolmax.com - American Consumer News: Lifesci Capital Comments on Tenaya Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:TNYA)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Lifesci Capital Comments on Tenaya Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:TNYA)

Newstex Global Business Blogs, 2024

Copyright Newstex May 18, 2024

Digital Resources/Online E-Resources

2
Watchlist News - American Consumer News: Tenaya Therapeutics’ (TNYA) “Buy” Rating Reiterated at HC Wainwright
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Tenaya Therapeutics’ (TNYA) “Buy” Rating Reiterated at HC Wainwright

Newstex Finance & Accounting Blogs, 2024

Copyright Newstex May 18, 2024

Digital Resources/Online E-Resources

3
Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity Group
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity Group

Newstex Global Business Blogs, 2024

Copyright Newstex May 20, 2024

Digital Resources/Online E-Resources

4
Zolmax.com - American Consumer News: Q2 2024 Earnings Forecast for Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Issued By Leerink Partnrs
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Q2 2024 Earnings Forecast for Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Issued By Leerink Partnrs

Newstex Global Business Blogs, 2024

Copyright Newstex May 18, 2024

Digital Resources/Online E-Resources

5
Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)

Newstex Global Business Blogs, 2024

Copyright Newstex May 20, 2024

Digital Resources/Online E-Resources

6
American Banking and Market News - American Consumer News: Comparing Repligen (NASDAQ:RGEN) and Lexeo Therapeutics (NASDAQ:LXEO)
Material Type:
Web Resources
Add to My Research

American Banking and Market News - American Consumer News: Comparing Repligen (NASDAQ:RGEN) and Lexeo Therapeutics (NASDAQ:LXEO)

Newstex Finance & Accounting Blogs, 2024

Copyright Newstex May 18, 2024

Digital Resources/Online E-Resources

Searching Remote Databases, Please Wait